TY - JOUR JO - EuroIntervention TI - Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> The one-year randomised data of the ABSORB II trial showed that the everolimus-eluting bioresorbable scaffold and the everolimus-eluting metallic stent were comparable for the compo AU - Chevalier Bernard AU - Onuma Yoshinobu AU - Van Boven Adrianus J. AU - Piek J. Jan AU - Sabaté Manel AU - Helqvist Steffen AU - Baumbach Andreas AU - Smits Pieter C. AU - Kumar Ravindra AU - Wasungu Luc AU - Serruys Patrick W. VL - 12 IS - 9 Y1 - 20/10/2016 Y1 - 2016 DOI - 10.4244/EIJY16M08_01 SP - 1102 EP - 1107 KW - bioresorbable scaffold KW - everolimus KW - metallic stent KW - randomised trial PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/randomised-comparison-of-a-bioresorbable-everolimus-eluting-scaffold-with-a-metallic-everolimus-eluting-stent-for-ischaemic-heart-disease-caused-by-de-novo-native-coronary-artery-lesions-the-2-year-clinical-outcomes-of-the-absorb-ii-trial SN - 1774-024X ER -